Resolute Partners Group
- SEC CIK
- 0001800217
- Latest filing
- Aug 14, 2026
RXRX holding history
Recursion Pharmaceuticals, Inc. in every 13F filed by Resolute Partners Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RXRX overviewAll 13F holders of RXRXFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 15
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −14,670−100.0% | Sold out | Holders |
| Q3 2025 | 14,670 | $71.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 14,670 | $74.2K | <0.1% | +14,670 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −14,670−100.0% | Sold out | Holders |
| Q4 2024 | 14,670 | $99.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 14,670 | $96.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 14,670 | $110.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 14,670 | $146.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 14,670 | $144.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 14,670 | $112.2K | <0.1% | +3,668+33.3% | Added | Holders |
| Q2 2023 | 11,002 | $82.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 11,002 | $73.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 11,002 | $84.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 11,002 | $117.0K | <0.1% | +1,834+20.0% | Added | Holders |
| Q2 2022 | 9,168 | $75.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 9,168 | $66.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 9,168 | $157.0K | <0.1% | +9,168 | New | Holders |